Medline (MDLN) Cost of Revenue (2025 - 2026)

Medline (MDLN) reported Cost of Revenue of $5.5 billion for Q1 2026, up 14.34% year-over-year from $4.8 billion in Q1 2025, and up 14.34% on a QoQ basis from $4.8 billion in Q1 2025.

Medline (MDLN) has 2 years of Cost of Revenue data on file, last reported at $5.5 billion in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn 940.30 Mn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn 2.56 Bn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn 5.51 Bn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn 540.43 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn 548.50 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn 64.00 Mn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn 303.50 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn 328.90 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn 1.81 Bn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn 630.96 Mn

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 5.51 Bn
Mar 28, 2026 5.51 Bn
Mar 29, 2025 4.82 Bn
Mar 29, 2025 4.82 Bn